Chronic Urticaria: Study of BLU-808

We are testing a new medication, BLU-808, for people with chronic inducible and spontaneous urticaria. The study aims to understand its safety and how well it may help reduce symptoms.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Blu-808

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Region Hovedstaden
Department of Dermato-Venereology and Wound Healing Center
Frederiksberg, Denmark
Odense University Hospital
Department of Dermatology and Allergy Center
Odense, Denmark
Technische Universitaet Dresden
Department of Dermatology
Dresden, Germany

Sponsor: Blueprint Medicines Corp.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.